Koers Targeted Medical Pharma, Inc. Other OTC
Aandelen
TRGM
US8761401046
Farmaceutische producten
Omzet 2014 | 7,11 mln. 6,52 mln. | Omzet 2015 | 5,26 mln. 4,83 mln. | Marktkapitalisatie | 429K 394K |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -3 mln. -2,75 mln. | Nettowinst (verlies) 2015 | -3 mln. -2,75 mln. | EV/omzet 2014 | 1,28 x |
Nettoschuld 2014 | 3,71 mln. 3,4 mln. | Nettoschuld 2015 | 5,21 mln. 4,78 mln. | EV/omzet 2015 | 1,07 x |
K/w-verhouding 2014 |
-1,37
x | K/w-verhouding 2015 |
-0,14
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 38,35% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 84 | 01-02-11 | |
Director/Board Member | 80 | 04-03-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,40% | 45,54 mld. | |
+34,52% | 24,51 mld. | |
+27,12% | 16,48 mld. | |
+21,19% | 14,66 mld. | |
+71,91% | 14,3 mld. | |
-0,05% | 6,79 mld. | |
-11,84% | 6,73 mld. | |
+15,08% | 5,87 mld. | |
-8,87% | 5,73 mld. |